Yahoo Web Search

  1. Ad
    related to OTUSKA PHARMACEUTICAL CO
  1. Pretomanid, which will be available at $364 per treatment course, is only the third new medicine for drug-resistant tuberculosis to be approved in about 40 years, after J&J's bedaquiline and ...

  2. Edited Transcript of 4578.T earnings conference call or presentation 12-Nov-19 7:00am GMT

    Thomson Reuters StreetEvents via Yahoo FinanceNov 15 20:41 PM

    Four global products in the pharmaceutical segment increased 37.5% year-on-year, significantly contributing to the consolidated results. In addition, business profit...

  3. A newly approved three-drug treatment for tuberculosis will be available in 150 countries including India and South Africa, priced at $1,040 for a complete regimen, more than twice the cost ...

  4. A newly-approved three-drug treatment for tuberculosis will be available in 150 countries including India and South Africa, priced at $1,040 for a complete regimen, more than twice the cost ...

  1. Ads
    related to OTUSKA PHARMACEUTICAL CO